New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
_256_384.png)
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
CHL is strengthening its play in the fast-growing beauty and personal care sector
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
